PCSK9 in diabetic kidney disease-Reference-Cited by-同舟云学术

PCSK9 in diabetic kidney disease

Published:2016-08-09 Issue:9 Volume:46 Page:779-786
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Elewa Usama¹²³,Fernández-Fernández Beatriz¹²³,Mahillo-Fernández Ignacio¹,Martin-Cleary Catalina¹²³,Sanz Ana Belen¹²³,Sanchez-Niño Maria D¹²³,Ortiz Alberto¹²³

Affiliation:

1. IIS-Fundación Jiménez Díaz; School of Medicine; Universidad Autónoma de Madrid; Madrid Spain

2. Fundación Renal Iñigo Alvarez de Toledo-IRSIN; Madrid Spain

3. REDINREN; Madrid Spain

Funder

Instituto de Salud Carlos III

Federación Española de Enfermedades Raras

EUTOX

Sociedad Española de Nefrologia

ISCIII-RETIC REDinREN

Comunidad de Madrid

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12661/fullpdf

Reference41 articles.

1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;GBD 2013 Mortality and Causes of Death Collaborators;Lancet,2015

2. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure;Ortiz;Lancet,2014

3. KDIGO clinical practice guideline for lipid management in chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group;Kidney Int,2013

4. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events;Robinson;N Engl J Med,2015

5. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events;Sabatine;N Engl J Med,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review);International Journal of Molecular Medicine;2024-05-10

2. Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease;Antioxidants;2024-04-12

3. Increased serum PCSK9 levels are associated with renal function impairment in patients with type 2 diabetes mellitus;Renal Failure;2023-05-29

4. Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease;Pharmaceutics;2023-04-28

5. Is Our Increasing Understanding of PCSK9 and Lp(a) Metabolism the Key to Unlocking the Paradox of Statins Ineffectiveness in Reducing Cardiovascular Events in Advanced CKD?;SN Comprehensive Clinical Medicine;2022-07-12